Skip to main content
VRXA
NASDAQ Life Sciences

Veraxa Biotech Gets Positive Regulatory Feedback from Germany for Lead Cancer Therapy

Tom Rudovsky · Reported by FinanceWire
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.87
Mkt Cap
$59.139M
52W Low
$1.7
52W High
$27.36
52W Position info
10% above low
Off High info
93% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

VRXA is trading near its 52-week low of $1.7 (10% above the low).

Summary

Veraxa Biotech received Scientific Advice from Germany's Paul-Ehrlich-Institute (PEI) supporting the development strategy for its lead BiTAC-TCE program. The feedback provides early regulatory guidance on biological rationale, safety assessments, and non-clinical plans, reducing uncertainty before clinical trials. This follows the company's recent pipeline update and preclinical data presented at AACR 2026. For a $59M market cap biotech, any regulatory de-risking is material. The company is advancing a diversified oncology pipeline including bispecific T-cell engagers and ADCs.

At the time of this announcement, VRXA was trading at $1.87 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $59.1M. The 52-week trading range was $1.70 to $27.36. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: FinanceWire.


Price Chart

Share this article

Copied!

VRXA - Latest Insights

VRXA
Oct 13, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $0.950 info
Change: -$0.280 (-23%) info
Market Cap: $140.346M info
VRXA
Aug 10, 2026, 5:20 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.83
Real-time Price: $0.950 info
Change: -$0.880 (-48%) info
Market Cap: $140.346M info
VRXA
Jul 31, 2026, 5:13 PM EDT
Filing Type: F-1
Importance Score:
8
Price at Filing: $1.82
Real-time Price: $0.950 info
Change: -$0.870 (-48%) info
Market Cap: $140.346M info
VRXA
Jul 31, 2026, 5:13 PM EDT
Filing Type: F-1
Importance Score:
7
Price at Filing: $1.82
Real-time Price: $0.950 info
Change: -$0.870 (-48%) info
Market Cap: $140.346M info
VRXA
Jul 27, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.97
Real-time Price: $0.950 info
Change: -$1.02 (-52%) info
Market Cap: $140.346M info